Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Georg Dahmann is active.

Publication


Featured researches published by Georg Dahmann.


Molecular Diversity | 2013

Parallel synthesis of 7-heteroaryl-pyrazolo[1,5-a]pyrimidine-3-carboxamides

Sizana Ahmetaj; Nina Velikanje; Uroš Grošelj; Ines Šterbal; Benjamin Prek; Amalija Golobič; Drago Kočar; Georg Dahmann; Branko Stanovnik; Jurij Svete

A simple and practical four-step protocol for the parallel synthesis of 7-heteroaryl-pyrazolo[1,5-


Journal of Medicinal Chemistry | 2010

Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase

Tina Morwick; Frank Büttner; Charles L. Cywin; Georg Dahmann; Eugene R. Hickey; Scott Jakes; Paul Kaplita; Mohammed A. Kashem; Steven Kerr; Stanley Kugler; Wang Mao; Daniel R. Marshall; Zofia Paw; Cheng-Kon Shih; Frank Wu; Erick Richard Roush Young


ACS Combinatorial Science | 2012

Diversity-oriented synthesis of 1-substituted 4-aryl-6-oxo-1,6-dihydropyridine-3-carboxamides.

Jernej Baškovč; Georg Dahmann; Amalija Golobič; Uroš Grošelj; Drago Kočar; Branko Stanovnik; Jurij Svete

a


Zeitschrift für Naturforschung B | 2010

Parallel Solution-phase Synthesis of (2S,4E)-4-(Arylaminomethylidene)pyroglutamic Acids

Jurij Svete; Uroš Grošelj; Jernej Baškovč; Georg Dahmann; Branko Stanovnik


Bioorganic & Medicinal Chemistry Letters | 2007

Discovery of potent and selective PKC-θ inhibitors

Charles L. Cywin; Georg Dahmann; Anthony S. Prokopowicz; Erick Richard Roush Young; Ronald L. Magolda; Mario G. Cardozo; Derek Cogan; Darren Disalvo; John David Ginn; Mohammed A. Kashem; John P. Wolak; Carol Ann Homon; Thomas M. Farrell; Heather Grbic; Hanbo Hu; Paul Kaplita; Lisa H. Liu; Denice M. Spero; Deborah D. Jeanfavre; Kathy O’Shea; Della White; Joseph R. Woska; Maryanne L. Brown

a]pyrimidine-3-carboxamides was developed. The synthesis starts with transformation of commercially available 2-acetylpyridine and acetylpyrazine with


Archive | 2002

Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same

Georg Dahmann; Frank Himmelsbach; Helmut Wittneben; Alexander Pautsch; Anthony S. Prokopowicz; Bernd Krist; Gisela Schnapp; Martin Steegmaier; Martin Lenter; Andreas Schoop; Steffen Steurer; Walter Spevak


Archive | 1997

Pyrimido[5,4-d]pyrimidines, medicaments comprising these compounds, their use and processes for their preparation

Frank Himmelsbach; Thomas von Ruden; Georg Dahmann; Thomas Metz

N,


Archive | 2005

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

John Edward Park; Gerald Juergen Roth; Armin Heckel; Nveed Chaudhary; Trixi Brandl; Georg Dahmann; Matthias Grauert


Archive | 2001

Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments

Henning Priepke; Norbert Hauel; Leo Thomas; Michael Mark; Georg Dahmann

N,


Journal of Pharmacology and Experimental Therapeutics | 2004

Inhibition of epidermal growth factor receptor activity by two pyrimidopyrimidine derivatives.

Flavio Solca; Anke Baum; Elke Langkopf; Georg Dahmann; Karl-Heinz Heider; Frank Himmelsbach; Jacques C. A. van Meel

Collaboration


Dive into the Georg Dahmann's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wolfgang Wienen

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jurij Svete

University of Ljubljana

View shared research outputs
Researchain Logo
Decentralizing Knowledge